Word: fda
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...glorious 4-D with accompanying DVD - produce images that are impressive, showing facial features, hair, fingers, toes and even a fetus' sex. Some companies throw in a sound track to go with Baby's first video. But there may be risks. The U.S. Food and Drug Administration (FDA) issued a firm warning earlier this year in its consumer magazine. Although there are no reported cases of ultrasound causing harm to a fetus, the FDA says we simply Loh and Behold Avant-garde murals and imaginative furnishings characterise a new Singapore hotel Identity Parade An iconic style magazine marks its quarter...
...Debate over the issue, which has been simmering for more than a year, is complicated by the fact that depression alone makes suicide more likely and that the risks vary widely among different drugs. (Prozac, for example, seems to cause fewer problems than other drugs.) A decision by the FDA on new warning labels will probably come in September. Meanwhile, a study of 400 youths, in the Journal of the American Medical Association, concluded that Prozac works best when combined with cognitive-behavior therapy...
...mean hundreds of jerky, involuntary movements and can result in chronic sleep deprivation. A study reported in the journal Sleep found that Requip, a drug for Parkinson's disease, significantly reduced RLS symptoms and improved the quality of sleep. The drug is currently being reviewed for approval by the FDA. --By David Bjerklie
...there anything Botox can't do? The FDA last week approved the anti-wrinkle wonder drug for yet another use: drying out supersweaty armpits (a condition known as hyperhidrosis). In a trial of 322 patients, better than 80% cut their sweating by more than half--and these are folks who can sweat through a business suit in minutes. One treatment, which lasts six months, will cost $750. This brings to five the number of FDA-sanctioned uses for Botox. Can a cure for baldness be far behind...
Despite all the exhortations to stay out of the sun, a million Americans will develop skin cancer this year. The only good news for die-hard sun worshippers is that treatments are improving. The FDA just gave 3M Pharmaceuticals the go-ahead to market Aldara as a therapy for a common type of basal-cell carcinoma (BCC)--the first new topical approved for BCC in 25 years. In trials, cancerous lesions cleared up after three months for more than 80% of patients...